MTSR fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Metsera is a clinical-stage biopharmaceutical company that focuses on creating innovative therapies for obesity and metabolic conditions. The company advances a range of oral and injectable treatment options while integrating proprietary health technology tools for personalized care.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
MTSR does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company